VPIM
PDSB icon

Vanguard Personalized Indexing Management’s PDS Biotechnology PDSB Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,979
Closed -$18.6K – 2038
2025
Q2 		$18.6K Sell
13,979
-14,544
-51% -$19.7K ﹤0.01% 1911
2025
Q1 		$33.9K Buy
+28,523
New +$40.6K ﹤0.01% 1716

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Personalized Indexing Management's PDSB Position: Q3 2025 in Review

Vanguard Personalized Indexing Management sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 13,979 shares — an estimated $18.6K sold.

Vanguard Personalized Indexing Management first reported a position in PDSB in Q1 2025 and held it in 2 quarters. The position peaked at $33.9K in Q1 2025. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • Vanguard Personalized Indexing Management reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 13,979 PDS Biotechnology shares in Q3 2025, an estimated $18.6K.
  • Vanguard Personalized Indexing Management first reported a position in PDS Biotechnology in Q1 2025 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's PDS Biotechnology position peaked at $33.9K in Q1 2025.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2025, filed 31 Oct 2025.